BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 22, 2020
View Archived Issues
New renal imaging agent for the measurement of glomerular filtration rate
Read More
Selective inhibition of GSK-3alpha ameliorates the phenotype of a mouse model of fragile X syndrome
Read More
Heat Biologics initiates phase I study of PTX-35
Read More
Topline data from PRISM3 study of CP-101 for prevention of recurrent C. difficile Infection
Read More
Preclinical data presented for IDG-16177
Read More
GEMIN5 mutations linked to developmental delay, motor dysfunction and cerebellar atrophy
Read More
Serum EMC10 is tied to atherosclerosis and coronary artery disease
Read More
Tarapeutics Science patents PI3Kdelta inhibitors
Read More
Sinovent divulges Ret inhibitors
Read More
Shanghai Ennova Biopharmaceutical presents TRK inhibitors
Read More
Age and sex differences influence macrophage response
Read More
Boehringer Ingelheim Pharma describes new VNN1 inhibitors
Read More
New AR and/or GR antagonists presented by Nuvation Bio
Read More
Lasting clinical benefit seen with axi-cel CAR T-cell therapy in indolent non-Hodgkin's lymphoma
Read More
Multiracial study gives new diabetes insights
Read More
Newly identified cone-rod synaptic disorder phenotype associated with RIMS2 gene variants
Read More
Phase I trial evaluates autologous GD2 CAR T cells for DIPG and DMG
Read More
Variants in GINS3 gene result in Meier-Gorlin syndrome
Read More
Calico opens enrollment in phase I trial of ABBV-CLS-579 for locally advanced or metastatic tumors
Read More
Beneficial activity seen with ladarixin in phase II study in new-onset type 1 diabetes
Read More
Ridgeback begins phase II studies of EIDD-2801 for COVID-19
Read More
FSD reports topline data from first-in-human study of ultramicronized palmitoylethanolamide
Read More
FDA approves Gimoti for acute and recurrent diabetic gastroparesis
Read More
FDA issues new complete response letter for Contepo for cUTI
Read More
Favipiravir approved in India for mild to moderate COVID-19
Read More
New phase I trial evaluates UCD19 CAR T cells for relapsed/refractory B-cell NHL
Read More